The new program Doctor of Philosophy in Precision Medicine [PhD PM] by the College of Medicine and TRIPM at Gulf Medical University Has been Accredited by the Commission for Academic Accreditation (CAA), Ministry of Education, Higher Education Affairs, UAE.
The Main aim of the Dual PhD Program in Precision Medicine is to develop scientists and researchers with a health professional background seeking to become researchers nationally and internationally in this changing field of health care.
Precision Medicine involves the application of omics sciences and systems biology to understand the causes of patients’ disease at the molecular level and utilize the information to design targeted treatments to address that individual disease process. In essence, Precision Medicine is a medical model that proposes the customization of healthcare with medical decisions, treatments, practice or products tailored to the individual or group of patients instead of one drug-fits all models.
The Chancellor of GMU Prof. Hossam Hamdy Stated that “The PhD is a dual degree program in collaboration with Paris-Saclay University, France. we have joined hands to promote international exchanges, increase scientific cooperation, development of research and higher education at the Gulf Medical University and provide value to the UAE community at Large by Also giving priority to UAE nationals to join this program. University Paris Saclay is ranked in 2020 as number one university in France, 6 in Europe and 14th in the world.
Prof. Salem Chouaib, Director of the PhD program added “GMU Strategic Plan had identified Precision Medicine Research as its main research direction. This led to the development of the “Thumbay Research Institute for Precision Medicine (TRIPM)” with a research agenda, focusing on understanding the molecular, genetic and immunological basis of cancer, diabetics and cardiovascular diseases. The Doctorate School of Oncology Health at Paris Saclay will Host the students in more than 100 specialized labs “
The Dual PhD Program in Precision Medicine has a broad scope and allows the PhD students to explore and develop through research, new knowledge leading to new diagnostics, treatments and prevention of diseases.
The candidate will receive two PhD degrees, one from each institution. In this case, each PhD degree will bear the name of the degree issued by that institution as follows:
- PhD in Precision Medicine awarded by Gulf Medical University and
- PhD in Cancer, Biology, Medicine, Health awarded by Paris-Saclay University
Gulf Medical University (GMU) is a leading medical university in the Gulf region offering Medical and Health Professional Education in the field of Medicine, Dentistry, Pharmacy, Physiotherapy, Nursing, Medical Laboratory Sciences, Anesthesia & Surgical Technology, and Medical Imaging Sciences. The university Has 6 Colleges and 26 Accredited programs. To know more about the admissions of various programs please visit www.gmu.ac.ae
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.